2013 Biotech & Standards Conference Moderator: Stacy L. Springs

Stacy L. Springs
Director, Biomanufacturing Research Program (BioMAN) and Executive Director, MIT Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB), Center for Biomedical Innovation, Massachusetts Institute of Technology

Dr. Stacy Springs is the Director of the Biomanufacturing Research Program (BioMAN) at the MIT Center for Biomedical Innovation and the Executive Director of the MIT Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB).  BioMAN is a collaborative research and educational program in biotherapeutic manufacturing that involves biopharmaceutical manufacturers, vendors, regulators, other government stakeholders and academics. The objective of this program is to develop new knowledge, science, technologies and strategies for advancing the safe manufacture and global delivery of high quality biopharmaceuticals.  The CAACB was established to share information around adventitious agent contamination and risk mitigation for the benefit of the biopharmaceutical manufacturing industry and the patients receiving medications produced from cell culture.

Dr. Springs holds a Ph.D. in Chemistry from the University of Texas at Austin and gained postdoctoral training in protein and biophysical chemistry at Princeton University.  Prior to joining MIT, Stacy was a Sr. Scientist and Director of Collaborative Projects at Tetralogic Pharmaceuticals, an oncology drug discovery company based in Malvern, PA.